_id
69105021ccc777a4e85d53e4
Ticker
CLRPF
Name
Clarity Pharmaceuticals Ltd
Exchange
PINK
Address
National Innovation Centre, Sydney, NSW, Australia, 2015
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.claritypharmaceuticals.com
Description
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Last Close
2.235
Volume
1700
Current Price
2.4
Change
0.033
Last Updated
2026-01-02T11:32:41.483Z
Image
data:image/webp;base64,UklGRpQIAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSDYFAAANmS8wRPQ/SIS1trVnkyS11lpr4b9TWuvu0RKk+jPCgYMe9PEKHg78Iy57RnwGdPIY/qGHXfLzaQPCgI88cNTPK3mMAe+I14AwIA34UcQETMA7cg0/4V/+0m/91B/4c+/1frzbuyxcx1/5Fv5amXf6K+KaLjtKZAlfB33Qnyo7Q+WquAZ1+guS/Ge8Lyi5hqdIp7NGS1zHj9giR9r1PhJXVF2yIy1T73GriD+x6/QBq/KqUNUOgCrtdsZxr63Xvr0qp8ggAckGyzINe16Ncx/DhlLZBpFzfaS5pA8nSSBBeRsZ+y/pFCfFSDG15EgqeKl6Kt2xp8f4I5seqSo7WqWcuHipknBKmRZVKlE5ZmKqZE2blzvTTqNGiebjP290bsJV7pRBab2ENcu5jWxR66cc/9DtV70Z435jOc2CkCRrcHBVVkVetizR46P+e37H+H28yUueqc4Qlnpf9qYOUsgZiUGk8N3yZT/0b29atshRchZygTlsyR7OMU8AqthKfM9nrP2Y6ySPZwsntrMOourcj7fM06y0XbqXgh/7sOVDJBAXXEaAOFC1x4XHPpUHp9rTWszvumyAMkaWgsN2Ek5KdMV02OEC7lvanziNcgeJ0ItJ7XHv2B9ZO9MBflL+jdeWePJx2sNIZV58KY/LyLFUVTls0pnOy+UR9RPn812H903zVMSL1UyPP6b11ekcBZaJkY6R6a6G1/2gam97nl0c2In61Chlk2UQLdnJOY+IlFJmP4By2LXSeHQo7HTWdFWptENuAKVeWYoD1oDcT15K2OlwQHXVbHoLdxVFhc5vUxxkw66qkhRkaiQ0VeviSxypdbQXV2zTB6mQQSWRsiHSNKUqEKRjjjlmr/dtHcKocaZcg5SlLDXAhfWmpquysjXOWcQhxpztrOHcs2qWQhPAAy7rq3uTZKXqctMctLcbKiwPk8W0xHNuSzt7Y2abavXWL4ZSVpUrbLklnvs4K8WbfU0XosQBezOtbgLt+0af5iY/Y1MVvL6V0xlwGKXyVQ8W5f6we1U/3vH0352nesDHDJw98EGUWdx9wYOsyHHUrOnwU35tVbmAGyynEIfsLeJx//9/e6upABHSuj3xr2uX+givH/CYIA5aEZx9fOtmCz7p9hT7fvTf3BneWucyVeZmiwhSrfFiYnlI++4rHu6q1v0XWMjb3flNx+N245qzpUXp2Dhp1sOLzdr2u3C9+bRFkafam3HJ6Ie50qi7Rk9LYxBq8eKuRFI6i2yrkSOFcKGGMU5hj6Mk2A8R1bPTkcYJUY5Xo9NZKcagz2NEUGcWXXyAgD5ZzoymbGKg2DIrOnfQ2fGwPfSpiuSQzqpea4yEyrYNNM6oFPA6M/aLb+pURw6D3JWEDNPKAKojIibocU/nnUW1fBiUkOWOQm4MnDiWnCH1PZXZZ00iD2VhWRbQPNnUjKx0+F4JMV9RFcFhs9OrjI2UT2GRwk16dxJabmZPDw5cIU0QhcVTeyerUoHcu1V0KTgYuc0Ua8KICbTeDk14/P3t6jwns2buvMQaNlMrmRIpv62N5Uvufs6rlE5UTg4oW0+hwuVFNoGbcdmH+25dqhd5ACYOYcTTz85cszpc0amUrU6DVNG2SR9EPNlej7u1L+S02p2tZbJ5khsvVXCa8MD9uB2eexWCxiJX62iu4EJtMrsDlhQuRRU6u04XrmSFlN4SKpGNi+yKZlfqCkQWbqonkSqXsxARYRBXcDhbLOccSs0NRHKlHQK4LI8mNq5hIgOMEwTX0RUyeKTE9UwZqDS+BlZQOCA4AwAAUBAAnQEqQABAAD6xRJxJpyOioTXy7mDgFglsAMOpjf7ByoVq0L8zXtuzRRB5rDfHql2zvmK/ZH1Yf8B6qPNy6hX0AOky/dL0ujATMy7t1yUvMjuJvqXkHTifvqjUGpa2nP1lRYLgxEUJtWAlB+pLiGTtiX3DOiyeuGE1806T/hWz9BAKTopN/+1XgAD+/TZo6/kykgOrG095v939tzdfR05hz4aOFM2ylnYDrm5wJc0IZb07H2UyD8wRgBfuItOsYA8O6po9YoBM/0jWy5P9zPLPxO3wB3BFhF5PqGv2IU4BeWtL1Pil1hH3ugZakidZUullv4bojVG5KRcBcH4lv9PuqyqO2GPbR9hm61ARAfVx88zAXZ9jpniG0c0ktEMPXCFPzhOdKdrCZ9ZvlLP9cswe/j1wKK2/2kl7e+0JZ+JiN2xB2iv4xf755LPXnVSSfWPfcetmtm3U9v+7LmVZz5rqblchGWsNlqdFtbao6uGY1oODz2qcKpecbP/46v3MGZu406r1LbQOmU198h6hoaBVPKRBkzGhM1cc8adeLSgn4xKfiAvy8z7aiqjhnruvJXeFgkddiDWaaAOXzd5mA4QbxJjmgxnMrkDUiN8U/RYb+x/ebLYiHnVmTkMx9Z/BvuVoL1wJruiVFz8i35v2dip8rd2wjk6peNjZq0c/Gyrcjc6T0fDMTMG2OEPNHq4cY1KY2MChqCtqOmjKArVunx4ypY5aM5sEZ1A7YxnwCpDGTcSCnaYy6skTe5fxkZBMPtCWLIgLQrXPS+9qxqyyCcVq7DHZEY7c/spSJAVQ1dxm7gSpPxTaVhl5f98BrkNnWA7p0WiBCBcuZSHSbbta+VNDD9W3bxnJuzE/m1kfeFxFKyx+I+FBQjfyHa/y9N53RVZRKuUi3FT579f+qtWIo81f6iJOZsp7cV30C2bRoc2sdfR9q4n4sxm5M7cHfRFuw1NxO4jv5r63VtzumNPFFCJSvNypV5hW2lkeNHpoCcNhiidNeDvUk/df5/fzFEgDhz9cYMJlUd7KuDl5REoUTfH89QZd4VYk9uFZ/8z4zcee8kb+xJ+sWUW+4759/kgnkvQq2pCgAAA=
Ipo Date
-
Market Cap
843764160
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
372030071
Income Tax Expense
22651
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
31213092
Short Term Investments
33801828
Receivables
10002212
Inventories
-
Total Current Assets
76677921
Property Plant Equipment
206142
Total Assets
76896406
Payables
2846510
Short Term Debt
-
Long Term Debt
-
Total Liabilities
7720738
Equity
69175668
Bs_currency_symbol
USD
Depreciation
26517
Change In Working Capital
-
Cash From Operations
-5481874
Capital Expenditures
13530
Cash From Investing
-7914445
Cash From Financing
63858
Net Change In Cash
-13337595
Cf_currency_symbol
USD
PE
-
PB
4.583649730711672
ROE
-
ROA
-
FCF
-5495404
Fcf Percent
-
Piotroski FScore
0
Health Score
55
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
2.5
Garp Investing Score
1.5
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
132115430
Quarters > 0 > income Statement > income Tax Expense
22651
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
31213092
Quarters > 0 > balance Sheet > short Term Investments
33801828
Quarters > 0 > balance Sheet > receivables
10002212
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
76677921
Quarters > 0 > balance Sheet > property Plant Equipment
206142
Quarters > 0 > balance Sheet > total Assets
76896406
Quarters > 0 > balance Sheet > payables
2846510
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7720738
Quarters > 0 > balance Sheet > equity
69175668
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-6679895
Quarters > 0 > cash Flow > depreciation
26517
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-5481874
Quarters > 0 > cash Flow > capital Expenditures
13530
Quarters > 0 > cash Flow > cash From Investing
-7914445
Quarters > 0 > cash Flow > cash From Financing
63858
Quarters > 0 > cash Flow > net Change In Cash
-13337595
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
4.583649730711672
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-5495404
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
55
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
22651
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
10002212
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
76677921
Quarters > 1 > balance Sheet > property Plant Equipment
206142
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
2846510
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7542040
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6679895
Quarters > 1 > cash Flow > depreciation
26517
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-5481874
Quarters > 1 > cash Flow > capital Expenditures
13530
Quarters > 1 > cash Flow > cash From Investing
-7914445
Quarters > 1 > cash Flow > cash From Financing
63858
Quarters > 1 > cash Flow > net Change In Cash
-13337595
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-5495404
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
28949
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
12689111
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
89451498
Quarters > 2 > balance Sheet > property Plant Equipment
232113
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
2310106
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7810533
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5621328
Quarters > 2 > cash Flow > depreciation
23740
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-8268105
Quarters > 2 > cash Flow > capital Expenditures
9751
Quarters > 2 > cash Flow > cash From Investing
9489951
Quarters > 2 > cash Flow > cash From Financing
51934
Quarters > 2 > cash Flow > net Change In Cash
1275977
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-8277856
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
28949
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
12689111
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
89451498
Quarters > 3 > balance Sheet > property Plant Equipment
232113
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
2310106
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
7810533
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-5621328
Quarters > 3 > cash Flow > depreciation
23740
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-8268105
Quarters > 3 > cash Flow > capital Expenditures
9751
Quarters > 3 > cash Flow > cash From Investing
9489951
Quarters > 3 > cash Flow > cash From Financing
51934
Quarters > 3 > cash Flow > net Change In Cash
1275977
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-8277856
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-78556853
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-63878929
Annuals > 0 > income Statement > net Income
-64295435
Annuals > 0 > income Statement > eps
-0.200003460958786
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
321471612
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
9915494
Annuals > 0 > income Statement > currency_symbol
AUD
Annuals > 0 > balance Sheet > cash
47684182
Annuals > 0 > balance Sheet > short Term Investments
36434166
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
100605979
Annuals > 0 > balance Sheet > property Plant Equipment
552462
Annuals > 0 > balance Sheet > total Assets
101171974
Annuals > 0 > balance Sheet > payables
3206143
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
10941462
Annuals > 0 > balance Sheet > equity
90230512
Annuals > 0 > balance Sheet > currency_symbol
AUD
Annuals > 0 > cash Flow > net Income
-64295435
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
182743
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
2211148
Annuals > 0 > cash Flow > net Change In Cash
-570322
Annuals > 0 > cash Flow > currency_symbol
AUD
Annuals > 0 > ratios > PE
-0.200003460958786
Annuals > 0 > ratios > PB
8.080388771549915
Annuals > 0 > ratios > ROE
-71.25686597012772
Annuals > 0 > ratios > ROA
-63.550638045275264
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-56307322
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-42029277
Annuals > 1 > income Statement > net Income
-42324428
Annuals > 1 > income Statement > eps
-0.1358093541658275
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
311645897
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
11506665
Annuals > 1 > income Statement > currency_symbol
AUD
Annuals > 1 > balance Sheet > cash
47900692
Annuals > 1 > balance Sheet > short Term Investments
88604970
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
154061379
Annuals > 1 > balance Sheet > property Plant Equipment
554802
Annuals > 1 > balance Sheet > total Assets
154629207
Annuals > 1 > balance Sheet > payables
2084373
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
8331757
Annuals > 1 > balance Sheet > equity
146297450
Annuals > 1 > balance Sheet > currency_symbol
AUD
Annuals > 1 > cash Flow > net Income
-42324430
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
504005
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
115212978
Annuals > 1 > cash Flow > net Change In Cash
16668045
Annuals > 1 > cash Flow > currency_symbol
AUD
Annuals > 1 > ratios > PE
-0.1358093541658275
Annuals > 1 > ratios > PB
4.831341177826407
Annuals > 1 > ratios > ROE
-28.930393523605503
Annuals > 1 > ratios > ROA
-27.37156118248734
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
37
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
-36164062
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-24499246
Annuals > 2 > income Statement > net Income
-24602446
Annuals > 2 > income Statement > eps
-0.18621932351126586
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
132115430
Annuals > 2 > income Statement > income Tax Expense
103200
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
9800556
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
31213092
Annuals > 2 > balance Sheet > short Term Investments
33801828
Annuals > 2 > balance Sheet > receivables
10002212
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
76677921
Annuals > 2 > balance Sheet > property Plant Equipment
206142
Annuals > 2 > balance Sheet > total Assets
76896406
Annuals > 2 > balance Sheet > payables
2846510
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7720738
Annuals > 2 > balance Sheet > equity
69175668
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-24602450
Annuals > 2 > cash Flow > depreciation
100513
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-27499957
Annuals > 2 > cash Flow > capital Expenditures
46562
Annuals > 2 > cash Flow > cash From Investing
3151012
Annuals > 2 > cash Flow > cash From Financing
231584
Annuals > 2 > cash Flow > net Change In Cash
-24123236
Annuals > 2 > cash Flow > currency_symbol
AUD
Annuals > 2 > ratios > PE
-0.18621932351126586
Annuals > 2 > ratios > PB
4.33154899552253
Annuals > 2 > ratios > ROE
-35.565173002738476
Annuals > 2 > ratios > ROA
-31.994272918294776
Annuals > 2 > ratios > FCF
-27546519
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
38
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-30290969
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-23736951
Annuals > 3 > income Statement > net Income
-23754583
Annuals > 3 > income Statement > eps
-0.09209388372323356
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
257938769
Annuals > 3 > income Statement > income Tax Expense
17632
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
6458925
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
55336328
Annuals > 3 > balance Sheet > short Term Investments
37000000
Annuals > 3 > balance Sheet > receivables
6657573
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
99550106
Annuals > 3 > balance Sheet > property Plant Equipment
260092
Annuals > 3 > balance Sheet > total Assets
99821943
Annuals > 3 > balance Sheet > payables
2849747
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
7585409
Annuals > 3 > balance Sheet > equity
92236534
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-23754580
Annuals > 3 > cash Flow > depreciation
46249
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-13313918
Annuals > 3 > cash Flow > capital Expenditures
213148
Annuals > 3 > cash Flow > cash From Investing
-26713513
Annuals > 3 > cash Flow > cash From Financing
86927851
Annuals > 3 > cash Flow > net Change In Cash
46897260
Annuals > 3 > cash Flow > currency_symbol
AUD
Annuals > 3 > ratios > PE
-0.09209388372323356
Annuals > 3 > ratios > PB
6.342444828770343
Annuals > 3 > ratios > ROE
-25.753984858104058
Annuals > 3 > ratios > ROA
-23.796955144421503
Annuals > 3 > ratios > FCF
-13527066
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PB
4.583649730711672
Valuation > final Score
34.163502692883284
Valuation > verdict
52.8% Overvalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.11161060273389771
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
26.937520331915223
Liquidity > metrics > Quick Ratio
26.937520331915223
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:37:04.545Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AClarity Pharmaceuticals Ltd's (ASX:CU6) top owners are individual investors with 58% stake, while 18% is held by insiders Yahoo Finance
Read more →(Last Updated 2023-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Clarity Pharmaceuticals Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.